Thursday, February 20, 2025 | 02:21 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Domestic business, US launches to drive gains for Zydus Lifesciences

Q3 results better than estimates on the back of higher gross margins

zydus lab
Premium

Representative Picture

Ram Prasad Sahu

Listen to This Article

The stock of pharma major Zydus Lifesciences hit lifetime highs this week and has gained 40 per cent over the last three months. More than half the gains for the stock came in the last one month. 

The company’s December quarter results earlier this month were better than Street estimates on the back of higher gross margins and a strong showing in the domestic formulations segment. This, coupled with a strong US pipeline and investments in multiple medium-term opportunities, has kept investor sentiment positive for the stock.

Consolidated revenues for the company were up by 6 per cent and was led by

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in